bioAffinity Technologies, Inc. BIAF 深 滬
已收盤 09-26 16:00:00 美东时间
5.29
+1.880
+55.13%
華盛通- 最 高7.29
- 今 開6.18
- 成交量 9988.93万股
- 最 低 4.65
- 昨 收 3.41
- 總市值 521.38万
- 52周最高 67.116
- 市盈率 靜 --
- 換手率 10134.87%
- 52周最低 3.40
- 委 比 39.21%
- 總股本 98.56万
- 歷史最高 466.50
- 量 比 396.43
- 振 幅 77.42%
- 歷史最低 4.02
- 每 手 1
- 風險率 15.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多bioAffinity Stock Up Over 50%: What's Driving the Surge?
Shares of bioAffinity Technologies Inc. (NASDAQ: BIAF) are trading higher Friday after the biotech company released case studies affirming the performance of one of its products</
今天 02:06
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers bioAffinity Technologies (NASDAQ: BIAF) stock increased by 71.8% to $5.86 during Friday's pre-market session. The company's market cap stands at $4.5 million.
09-26 20:10
bioAffinity Technologies Releases Three Additional Case Studies; One Case Study Includes CyPath Lung Detecting Stage 1A Lung Cancer
Noninvasive diagnostic test again leads to detecting Stage 1A lung cancer
09-26 20:07
bioAffinity Technologies Implements Reverse Stock Split
An update from bioAffinity Technologies, Inc. ( ($BIAF) ) is now available. On ...
09-18 05:01
bioAffinity to implement 1-for-30 reverse stock split
bioAffinity Technologies (NASDAQ:BIAF) plans to execute a 1-for-30 reverse split of its common stock to bring itself into compliance with Nasdaq’s minimum bid price requirement. Commencing with the op...
09-17 20:32
bioAffinity Technologies shares are trading higher after the company announced it received a notice of allowance for a U.S. patent titled "DETECTION OF EARLY-STAGE LUNG CANCER IN SPUTUM USING AUTOMATED FLOW CYTOMETRY AND MACHINE LEARNING"
bioAffinity Technologies shares are trading higher after the company announced ...
09-13 04:08
bioAffinity Technologies Unveils New CyPath® Lung Case Study
bioAffinity Technologies, Inc. ( ($BIAF) ) just unveiled an update. On Septembe...
09-10 04:56
U.S. Medicine Features bioAffinity's CyPath Lung Test For Enhanced VA Lung Cancer Detection And Cost Reduction
Noninvasive diagnostic can help federal medical system address veterans at higher risk for developing lung cancerU.S. Medicine, a leading publication for federal healthcare professionals, has featured bioAffinity
09-03 20:13
bioAffinity Amends Warrant Floor Price in Recent Agreement
bioAffinity Technologies, Inc. ( ($BIAF) ) just unveiled an update. On Septembe...
09-02 21:54
bioAffinity Technologies Appoints New Board Members
bioAffinity Technologies, Inc. ( ($BIAF) ) has provided an announcement. On Aug...
08-19 04:53
